Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disorders

Psychoneuroendocrinology

Volumn 25, Issue 6, 2000, Pages 593-606

  Regenold, William T ^a   A Kling, Mitchel ^a   Hauser, Peter ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Cerebrospinal fluid; Diabetes mellitus; Mood disorder; Polyols; Sorbitol

Indexed keywords

POLYOL; SORBITOL;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGING; BIPOLAR DISORDER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MOOD DISORDERS; REFERENCE VALUES; SORBITOL;

EID: 0034118468     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(00)00012-3     Document Type: Article

References (61)

1. Altshuler L.L., Curran J.G., Hauser P., Mintz J., Denicoff K., Post R. T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. Am. J. Psychiatry. 152:1995;1139-1144.
2. Barkai A.I., Dunner D.L., Gross H.A., Mayo P., Fieve R.R. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol. Psychiatry. 13:1978;65-72.
3. Cassidy F., Ahearn E., Carroll B.J. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am. J. Psychiatry. 156:1999;1417-1420.
4. Catanese V.M., Kahn R.C. Secondary forms of diabetes. Becker K.L. Principles and Practice of Endocrinology and Metabolism, 2nd ed. 1995;1220-1227 J.B. Lippincott Company, Philadelphia.
5. Chu P.C., Lin M.T., Shian L.R., Leu S.Y. Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats. Diabetes. 35:1986;481-485.
6. Coffey C.E., Figiel G.S., Djang W.T., Saunders W.B., Weiner R.D. White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly. J. Neuropsychiatry Clin. Neurosci. 1:1989;135-144.
7. Davson H., Welch K., Segal M.B. Physiology and Pathophysiology of the Cerebrospinal Fluid. 1987;Churchill Livingstone, Edinburgh, New York.
8. Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu. Rev. Med. 49:1998;341-361.
9. Dupont R.M., Jernigan T.L., Butters N., Delis D., Hesselink J.R., Heindel W., Gillin J.C. Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging, clinical and neuropsychological significance. Arch. Gen. Psychiatry. 47:1990;55-59.
10. Dupont R.M., Jernigan T.L., Gillin J.C., Butters N., Delis D.C., Hesselink J.R. Subcortical signal hyperintensities in bipolar patients detected by MRI. Psychiatry Res. 21:1987;357-358.
11. Dyck P.J., Zimmerman B.R., Vilen T.H., Minnerath S.R., Karnes J.L., Yao J.K., Poduslo J.F. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N. Engl. J. Med. 319:1988;542-548.
12. Ellenberg M. Diabetic neuropathy: clinical aspects. Metabolism. 25:1976;1627-1655.
13. Fazekas F., Niederkorn K., Schmidt R., Offenbacher H., Horner S., Bertha G., Lechner H. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke. 19:1988;1285-1288.
14. Funasako M., Fujimoto K., Taniji M., Suruda T., Nakai S., Kobayashi H., Sakagami Y., Ohata M. Effect of ageing on erythrocyte aldose reductase and sorbitol dehydrogenase activity. Mech. Aging Dev. 73:1994;137-143.
15. Gavard J.A., Lustman P.J., Clouse R.E. Prevalence of depression in adults with diabetes, an epidemiological evaluation. Diabetes Care. 16:1993;1167-1178.
16. Geringer E.S., Perlmuter L.C., Stern T.A., Nathan D.M. Depression and diabetic neuropathy: a complex relationship. J. Geriatr. Psychiatry Neural. 1:1988;11-15.
17. Goldstein L.E., Sporn J., Brown S., Kim H., Finkelstein J., Gaffey G.K., Sachs G., Stern T.A. New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics. 40:1999;438-443.
18. Goodnick P.J., Henry J.H., Buki V.M. Treatment of depression in patients with diabetes mellitus. J. Clin. Psychiatry. 56:1995;128-136.
19. Goodwin F.K., Jamison K.R. Manic-depressive Illness. 1990;University Press, New York/Oxford.
20. Greene D.A., Lattimer S.A., Sima A.A. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316:1987;599-606.
21. Griffey R.H., Eaton R.P., Sibbitt R.R., Sibbitt W.L. Jr., Bicknell J.M. Diabetic neuropathy. Structural analysis of nerve hydration by magnetic resonance spectroscopy. Jama. 260:1988;2872-2878.
22. Gutniak M., Blomqvist G., Widen L., Stone-Elander S., Hamberger B., Grill V. D-[U-11C]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am. J. Physiol. 258:1990;E805-E812.
23. Hale P.J., Nattrass M., Silverman S.H., Sennit C., Perkins C.M., Uden A., Sundkvist G. Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients. Diabetologia. 30:1987;464-467.
24. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
25. Haskett R.F. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am. J. Psychiatry. 142:1985;911-916.
26. Heesom A.E., Millward A., Demaine A.G. Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene. J. Neurol. Neurosurg. Psychiatry. 64:1998;213-216.
27. Hickie I., Scott E., Mitchell P., Wilhelm K., Austin M.P., Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol. Psychiatry. 37:1995;151-160.
28. Hu M., Wu H., Chao C. Assisting effects of lithium on hypoglycemic treatment in patients with diabetes. Biol. Trace Elem. Res. 60:1997;131-137.
29. Isojarvi J.I. Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy. Epilepsia. 31:1990;438-445.
30. Kawamura M.E.G., Kopin I.J., Kador P.F., Lee Y.S., Tsai J.Y., Fujisawa S., Lizak M.J., Sinz A., Sato S. Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats. Biochem. Pharmacol. 58:1999;517-524.
31. Kennedy S.H., Javanmard M., Vaccarino F.J. A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Can. J. Psychiatry. 42:1997;467-475.
32. Kishimoto M., Kajimoto Y., Kubota M., Watarai T., Shiba Y., Kawamori R., Inaba T., Kamada T., Yamasaki Y. Sensitive, selective gas chromatographic-mass spectrometric analysis with trifluoroacetyl derivatives and a stable isotope for studying tissue sorbitol-producing activity. J. Chromatogr. B Biomed. Sci. Appl. 688:1997;1-10.
33. Kling M.A., DeBellis M.D., O'Rourke D.K., Listwak S.J., Geracioti T.D. Jr., McCutcheon I.E., Kalogeras K.T., Oldfield E.H., Gold P.W. Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers. J. Clin. Endocrinol. Metab. 79:1994;233-239.
34. Kling M.A., Neuhaus I., Gold P.W. Psychiatric-hormonal interrelationships. Becker K.L. Principles and Practice of Endocrinology and Metabolism, 2nd ed. 1995;1696-1702 J.B. Lippincott Company, Philadelphia.
35. Kooy F.H. Hyperglycemia in mental disorders. Brain. 42:1919;214-289.
36. Lackovic Z., Salkovic M., Kuci Z., Relja M. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J. Neurochem. 54:1990;143-147.
37. Lilliker S.L. Prevalence of diabetes in a manic-depressive population. Compr. Psychiatry. 21:1980;270-275.
38. Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 4(Suppl. 2):1997;S38-S42.
39. Martinot J.L., Hardy P., Feline A., Huret J.D., Mazoyer B., Attar-Levy D., Pappata S., Syrota A. Left prefrontal glucose hypometabolism in the depressed state: a confirmation [see comments]. Am. J. Psychiatry. 147:1990;1313-1317.
40. Mueller P.S., Heninger G.R., McDonald R.K. Insulin tolerance test in depression. Arch. Gen. Psychiatry. 21:1969;587-594.
41. Mueller P.S., Heninger G.R., McDonald R.K. Intravenous glucose tolerance test in depression. Arch. Gen. Psychiatry. 21:1969;470-477.
42. Obembe A. Carbamazepine-induced diabetes mellitus. Cent. Afr. J. Med. 37:1991;96-98.
43. Ohtani N., Ohta M., Sugano T. Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J. Neurochem. 69:1997;1622-1628.
44. Ostenson C.G., Cattaneo A.G., Doxey J.C., Efendic S. Alpha-adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats. Am. J. Physiol. 257:1989;E439-E443.
45. Perini G.I., Devinsky O., Hauser P., Gallucci W.T., Theodore W.H., Chrousos G.P., Gold P.W., Kling M.A. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers. J. Clin. Endocrinol. Metab. 74:1992;406-412.
46. Perros P., Deary I.J., Sellar R.J., Best J.J., Frier B.M. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care. 20:1997;1013-1018.
47. Quatraro A., Consoli G., Stante A., Minei A., Ceriello A., Passariello N., Giugliano D. Impaired insulin secretion in human diabetes mellitus. Effect of pharmacological activation of gamma-aminobutyric acid system. Acta. Diabetol. Lat. 23:1986;23-28.
48. Renner F., Schmitz A., Gehring H. Rapid and sensitive gas chromatography-mass spectroscopy method for the detection of mannitol and sorbitol in serum samples. Clin. Chem. 44:1998;886-887.
49. Rubinow D.R., Post R.M., Gold P.W., Uhde T.W. Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness. Psychopharmacology. 88:1986;115-118.
50. Schmidt R., Fazekas F., Kleinert G., Offenbacher H., Gindl K., Payer F., Freidl W., Niederkorn K., Lechner H. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch. Neurol. 49:1992;825-827.
51. Schwartz J.M., Baxter L.R. Jr., Mazziotta J.C., Gerner R.H., Phelps M.E. The differential diagnosis of depression. Relevance of positron emission tomography studies of cerebral glucose metabolism to the bipolar-unipolar dichotomy. Jama. 258:1987;1368-1374.
52. Servo C., Bergstrom L., Fogelholm R. Cerebrospinal fluid sorbitol and myoinositol in diabetic polyneuropathy. Acta. Med. Scand. 202:1977;301-304.
53. Shetty H.U., Holloway H.W., Rapoport S.I. Capillary gas chromatography combined with ion trap detection for quantitative profiling of polyols in cerebrospinal fluid and plasma. Anal. Biochem. 224:1995;279-285.
54. Shetty H.U., Schapiro M.B., Holloway H.W., Rapoport S.I. Polyol profiles in Downs syndrome. myo-inositol, specifically, is elevated in the cerebrospinal fluid. J. Clin. Invest. 95:1995;542-546.
55. Shetty H.U., Holloway H.W., Schapiro M.B. Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin. Chem. 42:1996;298-302.
56. Shimon H., Agam G., Belmaker R.H., Hyde T.M., Kleinman J.E. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am. J. Psychiatry. 154:1997;1148-1150.
57. SPSS Inc., 1993. SPSS base system syntax reference guide, release 6.0, SPSS, Chicago, Ill.
58. Velde C.D.v.d., Gordon M.W. Manic-depressive illness, diabetes mellitus, and lithium carbonate. Arch. Gen. Psychiatry. 21:1969;478-485.
59. Vestergaard P., Schou M. Does long-term lithium treatment induce diabetes mellitus? Neuropsychobiology. 17:1987;130-132.
60. Viinamaki H., Niskanen L., Uusitupa M. Mental well-being in people with non-insulin-dependent diabetes. Acta. Psychiatr. Scand. 92:1995;392-397.
61. Whittle S.R., Turner A.J. Biogenic aldehyde metabolism in rat brain. Differential sensitivity of aldehyde reductase isoenzymes to sodium valproate. Biochim. Biophys. Acta. 657:1981;94-105.